STXBP1 and epilepsy: Although several studies demonstrated that LEV showed effectiveness on epilepsy with genetic alteration (e.g., CACNA1 and STXBP1 mutation) [33,34], studies based on the efficacy of LEV as a treatment for epilepsy with genetic alterations are very scarce.